Ipamorelin vs Hexarelin
Community accounts comparing ipamorelin and hexarelin for GH release — cleaner pulse vs stronger pulse, side effect trade-offs, and which fits ongoing protocols.
0 anonymous reports
We're collecting more reports on this topic.
Submit yourscommunity guides:
Community Q&A
- What is the difference between ipamorelin and hexarelin?
- Both are GHRPs — they stimulate GH release through the ghrelin receptor — but community accounts describe them as meaningfully different in profile. Ipamorelin is characterised in confessions as the cleanest GHRP: selective GH release with minimal cortisol or prolactin spike, low water retention, and no meaningful desensitisation at standard doses. Hexarelin is described as producing a stronger GH pulse, but accounts consistently note the trade-off: a cortisol and prolactin spike accompanies the stronger GH release, and desensitisation is described as occurring within weeks of continuous use. The community shorthand: ipamorelin for sustainable ongoing protocols; hexarelin for short, aggressive GH cycles where maximum pulse strength is the priority.
- Which is better for GH release — ipamorelin or hexarelin?
- For raw GH pulse strength, community accounts give hexarelin the edge — it is described as producing a stronger, more acute GH release than ipamorelin at comparable doses. But accounts consistently contextualise this: the hexarelin GH pulse comes with cortisol and prolactin elevation that attenuates some of the anabolic benefit and limits how long the compound can be used continuously. Ipamorelin accounts describe a cleaner, more repeatable pulse — not as strong in any single instance, but sustainable across longer protocols without desensitisation. For body composition outcomes over 3–6 months, accounts running ipamorelin plus a GHRH analogue (CJC-1295 or sermorelin) describe comparable or better results than hexarelin alone, with fewer side effects.
- Does hexarelin cause more side effects than ipamorelin?
- Community accounts consistently describe hexarelin as having a heavier side effect burden than ipamorelin. The most commonly cited differences: hexarelin produces cortisol and prolactin spikes that ipamorelin does not; water retention is more pronounced in hexarelin accounts; and hexarelin causes more rapid desensitisation — accounts describe needing to cycle off after 4–8 weeks to restore sensitivity, whereas ipamorelin accounts describe much slower desensitisation onset. Hexarelin also appears in more accounts describing gynecomastia concerns due to prolactin elevation. The recurring reason in accounts for choosing ipamorelin over hexarelin: the side effect trade-off for the stronger GH pulse is not considered worth it for most wellness and body composition goals.
- Can you stack ipamorelin and hexarelin?
- Stacking ipamorelin and hexarelin is uncommon in community accounts — both act on the same GHRP/ghrelin receptor pathway, so the combination produces receptor competition and diminishing returns rather than synergy. Accounts that tried the combination describe side effects compounding (more cortisol, more water retention) without proportionally better GH release. The comparison stacks that produce consistently stronger results in community accounts: pairing either GHRP with a GHRH analogue (ipamorelin + CJC-1295, or hexarelin + CJC-1295) to stimulate both the GHRP and GHRH receptor pathways simultaneously. That synergistic combination is what most performance-focused accounts describe as the standard approach.